Fig. 1From: Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseaseSummary of the main challenges surrounding the implementation of the NICE TA715 guideline updates. Abbreviations: NICE, National Institute for Health and Care Excellence; PROM, patient-reported outcome measure; RA, rheumatoid arthritisBack to article page